000 01336 a2200373 4500
005 20250511213159.0
264 0 _c19911220
008 199112s 0 0 eng d
022 _a0090-1229
024 7 _a10.1016/s0090-1229(05)80005-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNorton, F L
245 0 0 _aResponse of huSCID mice reconstituted with lymphocytes from anti-idiotype-treated melanoma patients.
_h[electronic resource]
260 _bClinical immunology and immunopathology
_cDec 1991
300 _a332-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntibodies, Anti-Idiotypic
_xtherapeutic use
650 0 4 _aAntibody Formation
650 0 4 _aHumans
650 0 4 _aImmunization
650 0 4 _aImmunoglobulin G
_ximmunology
650 0 4 _aImmunoglobulin Idiotypes
_ximmunology
650 0 4 _aImmunotherapy
650 0 4 _aLymphocytes
_ximmunology
650 0 4 _aMelanoma
_xtherapy
650 0 4 _aMice
650 0 4 _aMice, SCID
_xblood
650 0 4 _aTetanus Toxoid
_ximmunology
700 1 _aShuey, S R
700 1 _aKöhler, H
773 0 _tClinical immunology and immunopathology
_gvol. 61
_gno. 3
_gp. 332-42
856 4 0 _uhttps://doi.org/10.1016/s0090-1229(05)80005-4
_zAvailable from publisher's website
999 _c1940820
_d1940820